Recurrent Verrucous Carcinoma of the Larynx Completed Phase 1 Trials for 7-Hydroxystaurosporine (DB01933)
Also known as: Laryngeal verrucous carcinoma recurrent / Recurrent Laryngeal Verrucous Carcinoma / Squamous Cell Carcinoma of the Larynx / Laryngeal squamous cell carcinoma / Primary squamous cell carcinoma of larynx (disorder) / Squamous cell carcinoma of larynx (disorder)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0029506 (Recurrent Verrucous Carcinoma of the Larynx) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | Treatment |